Arcadia Biosciences Annual Income Statement (NASDAQ:RKDA)

Add to My Stocks
$1.13 $0 (0.18%) RKDA stock closing price Dec 02, 2016 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Arcadia Biosciences stock price. In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. The income statement for RKDA which implies a YoY revenue decline of $1.57M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. 2015 revenue is $5.41M and has decreased from $6.98M year on year as is evident when you compare the latest figures in the latest Arcadia Biosciences profit and loss statement with those of the prior corresponding period. (See also:Arcadia Biosciences assets and Arcadia Biosciences free cash flow) Arcadia Biosciences revenue for 2015 is $5.41M. View revenue and profit details for latest and last 10 financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Sales or Revenues
5.41M6.98M6.47M
Cost Of Goods Sold (COGS)0.89M1.99M0.67M
Arcadia Biosciences Gross Profit
4.52M4.98M5.8M
Research & Development Expense8.96M10.01M8.4M
Selling General & Admin Expense11.11M10.12M7.96M
Income Before Depreciation Depletion Amortization-15.56M-15.15M-10.56M
Depreciation Depletion Amortization---
Non Operating Income0.29M-0.59M0.01M
Interest Expense2.65M1.39M0.62M
Arcadia Biosciences Pretax Income
-17.93M-17.14M-11.18M
Provision for Income Taxes0.02M0.26M0.16M
Minority Interest---
Investment Gains Losses--0.93M-1.84M
Other Income---
Income Before Extraordinaries & Disc Operations-17.95M-18.33M-13.19M
Extraordinary Items & Discontinued Operations---
Arcadia Biosciences Net Income (Profit/Loss)
-17.95M-18.33M-13.19M
Average Shares used to compute Diluted EPS28.56M2.06M-
Average Shares used to compute Basic EPS28.56M2.06M-
Income Before Nonrecurring Items-17.73M-18.34M-
Income from Nonrecurring Items-0.23M--
Arcadia Biosciences Earnings Per Share Basic Net
-0.73-10.71-
Arcadia Biosciences Earnings Per Share Diluted Net
-0.73-10.71-
EPS Diluted Before Nonrecurring Items-0.72-10.71-
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common---
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Income statement for another ticker

Arcadia Biosciences stock analysis involves checking at least a few of the important things like:
  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth (See: Arcadia Biosciences revenue chart) implies that the company is growing, which has not been the case with Arcadia Biosciences. One must stay away from stocks whose revenues are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. RKDA stock had a poor bottom line growth.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
12.5123
Operating margin
-363
Net profit margin
-387
Dividend yield
0%